soul trial oral semaglutide cardiovascular outcomes Effects of on in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized SOUL Trial Shows Oral Semaglutide

The truth, as usual, lives somewhere in between

For providers who have explored weight loss certification options and want a program that bridges the gap between academic knowledge and clinical practice, the AAOPM pathway delivers

10.1016/j.abb.2008.08.001

Some common side effects are: Digestive issues and nausea: Because GLP-1 slows digestion, food sitting in the stomach for longer periods of time can cause nausea or digestive discomfort Nutritional deficiencies: With appetite suppressants come less food intake, theres a risk of not getting enough of the vitamins and minerals that our bodies still need Low energy or fatigue: Some people may experience fatigue while taking GLP-1 but this effect is typically brief

Because many of these molecules cant be patented, pharmaceutical companies have little reason to fund those trials

This experience supports its reputation as a low-friction, high-control delivery tool that is easy to repeat day after day